After achieving clinical validation earlier this year, ReCode Therapeutics has called up a new CEO to take on the mission of advancing programs for cystic fibrosis and primary ciliary dyskinesia through the clinic.

Original title: “ReCode CEO Suliman leaves cystic fibrosis mission in mentee’s hands”

clinical characteristics of patients with fontan circulation and primary ciliary dyskinesia a case series from the sv one registry

Original title: “Clinical Characteristics of Patients With Fontan Circulation and Primary Ciliary Dyskinesia: A Case Series From the SV-ONE Registry.”

pulmonary exacerbations in primary ciliary dyskinesia

Original title: “Pulmonary exacerbations in primary ciliary dyskinesia.”

clinical outcomes of chronic airway infection in primary ciliary dyskinesia

Original title: “Clinical Outcomes of Chronic Airway Infection in Primary Ciliary Dyskinesia.”

hepatocyte growth factor in children of primary ciliary dyskinesia and its relation to disease severity a case control study

Original title: “Hepatocyte Growth Factor in Children of Primary Ciliary Dyskinesia and Its Relation to Disease Severity. A case-control study.”

evaluating the efficacy and safety of macrolide therapy in primary ciliary dyskinesia a systematic review

Original title: “Evaluating the efficacy and safety of macrolide therapy in primary ciliary dyskinesia: A systematic review.”

systematic reanalysis of whole exome sequencing in genetically unsolved pediatric primary ciliary dyskinesia

Original title: “Systematic Reanalysis of Whole-Exome Sequencing in Genetically Unsolved Pediatric Primary Ciliary Dyskinesia.”

primary ciliary dyskinesia insights from a portuguese tertiary centre cohort

Original title: “Primary Ciliary Dyskinesia: Insights from a Portuguese tertiary centre cohort.”

estimation of the genetic susceptibility prevalence of primary ciliary dyskinesia via the gnomad v4 1 0 database

Original title: “Estimation of the genetic susceptibility prevalence of primary ciliary dyskinesia via the gnomAD v4.1.0 database.”

multi omics analysis defines endotypes and systemic inflammation in primary ciliary dyskinesia a comparison with healthy controls

Original title: “Multi-Omics Analysis Defines Endotypes and Systemic Inflammation in Primary Ciliary Dyskinesia: A Comparison with Healthy Controls.”

first neonatal case of primary ciliary dyskinesia caused by a pathogenic drc1 variant presenting with recurrent atelectasis and airway hypersecretion a case report and literature review

Original title: “First neonatal case of primary ciliary dyskinesia caused by a pathogenic DRC1 variant presenting with recurrent atelectasis and airway hypersecretion: a case report and literature review.”

treatment of lung disease in primary ciliary dyskinesia a review of current and emerging interventions

Original title: “Treatment of Lung Disease in Primary Ciliary Dyskinesia: A Review of Current and Emerging Interventions.”

diagnosis of primary ciliary dyskinesia putting the european respiratory american thoracic guideline into practice

Original title: “The Diagnosis of Primary Ciliary Dyskinesia: Putting The European Respiratory/American Thoracic Guideline Into Practice.”

pcdsos a novel clinical predictive tool for screening primary ciliary dyskinesia in adult bronchiectasis patients a multicenter derivation and external validation study

Original title: “PCDSOS: a novel clinical predictive tool for screening primary ciliary dyskinesia in adult bronchiectasis patients-a multicenter derivation and external validation study.”